Bioscience Park Center
12635 East Montview Blvd
Aurora, CO 80045
T: 720.859.6116
F: 720.859.6123
info@beaconbiotechnology.com
  < About Us      < Enabling Discovery. Enhancing Life.  
 
  Meet our team.
Beacon Biotechnology was founded by a team of brilliant scientists and savvy business professionals with decades of experience in biomedical, commercial and academic settings.

CEO: Millard Cull, BS, MBA
Millard Cull is a co-founder and Chief Technology Officer of Beacon Biotechnology, and has over 15 years of experience in the biotechnology industry. In addition, Mr. Cull is CEO of Avidity, LLC, a technology company he co-founded in 1996. He has a BS in Molecular, Cellular and Developmental Biology from University of Colorado, Boulder, and an MBA in Finance from the University of Denver. Millard holds several patents in the field of Directed Molecular Evolution and a patent for the Replicative DNA Polymerase from Thermus Thermophylus. He co-authored a paper describing the first use of intercalating dyes in a DNA polymerase assay that served as a forerunner of quantitative PCR (qPCR). Finally, he is the lead inventor on several recently submitted patent applications including the Chemiluminescent Nucleic Acid Proximity Assay (NAPA™).

CFO: Larry Lansing, BS
Larry Lansing is a co-founder of Beacon Biotechnology, and together with Mr. Cull, founded Avidity, LLC in 1996. He serves as CFO of both Beacon and Avidity. He has over 25 years of accounting experience, initially as a Certified Public Accountant (CPA) with a focus on taxation and business consulting. Over the past ten years he has been instrumental in negotiating license agreements for use of Avidity’s patented AviTag™ technology with nine of ten of the world's largest pharmaceutical companies.

CSO: Ronald E. Gill, PhD
Chief Science Officer Dr. Ronald Gill has more than 25 years of biomedical research experience in both biotechnology and academic environments. He earned his PhD in Microbiology from the University of Washington and did post-doctoral work in Biochemistry at Stanford University. His background helps determine the scientific direction of the company. Dr. Gill is a Professor in the University of Colorado Denver School of Medicine and a Member and Senior Scientist with Avidity LLC.

Director and Scientific Advisor: John C. Cambier, PhD
Dr. John Cambier is the Ida and Cecil Green Professor and Chairman of the Department of Immunology at the University of Colorado Denver School of Medicine and National Jewish Health. He is cited on 52 papers and has authored or co-authored 5 books related to immunology. He is an accomplished, frequently invited guest speaker and has participated in numerous professional boards and committees and on the editorial board of several professional publications including the Journal of Clinical Immunology (2003–2007) and Immunological Reviews (2002–2007).